Considering the clinical findings that HCC patients are insensitive to chemotherapy and immunotherapy, ferroptosis induction may be a promising therapeutic strategy for HCC patients with high NEAT1 expression. This evidence concerns the gene NEAT1 and hepatocellular carcinoma.